Utilizing of quantitative proteomics to identify species-specific protein therapeutic target for treatment of leishmaniasis.

ABSTRACT: Identification of common Leishmania antigen proteins is important for practical purposes ranging from diagnostic to the development of a vaccine for the prevention of leishmaniasis. Moreover, we need to establish the potential drug targets that interrupt the replication and transmission of the pathogen to promote drug discovery. Therefore, the objective of this work was to provide the public proteome database which would be useful for the establishment of novel protein antigenicity for therapeutic purposes. This information would introduce the alternative protein targets for Leishmaniasis, allowing the development of therapeutic strategies for the disease.

INSTRUMENT(S):

ORGANISM(S): Leishmania Donovani Ld 2001

TISSUE(S): Cell Culture, Diploid Cell

DISEASE(S): Leishmaniasis

SUBMITTER: Sucheewin Krobthong  

LAB HEAD: Kiattawee Choowongkomon

PROVIDER: PXD026304 | Pride | 2022-05-20

REPOSITORIES: Pride